HSY vs RXRX · P/E 36, rev $5.89B vs rev $14.1M
Hershey Co (HSY) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Hershey Co (HSY) is a confectioners company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
HSY currently screens at market cap $39.36B and trailing P/E 36.1. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the HSY and RXRX stock pages for the full models.
Not investment advice.